OPKO Health 2024年第二季度GAAP每股收益$（0.01）击败$（0.09）估计，销售额1.822亿美元未达到1.8519亿美元估计

OPKO Health (NASDAQ: OPK) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.09) by 88.89 percent. The company reported quarterly sales of $182.200 million which missed the analyst consensus estimate of $185.190 million by 1.61 percent. This is a 31.35 percent decrease over sales of $265.400 million the same period last year.